The NCA produces cancer pathways for all tumour sites as part of the clinical guidelines for each EAG.
There are also hand books for the implementation of the national optimal pathways for :
As part of the Early Diagnosis transformation work the Alliance has supported service improvement capacity within most provider trusts in the region. These service improvement facilitators have worked with clinicians and performance teams in the trusts to support the delivery of the optimal pathways.
- Acute Myeloid Lymphoblastic Leukamia – AML and ALL
- Chronic Lymphocytic Leukaemia CLL
- Chronic Myeloid Leukaemia CML
OG and HPB